Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

Accelerated Vaccination

  • Read more about Accelerated Vaccination
Australia
2011200335
Filed on 2011-01-27

2-nitro-6(S),7-dihydro-5H-imidazo[2,1-b] [1,3]oxazines And Their Use Against Myocobacterium Tuberculosis

  • Read more about 2-nitro-6(S),7-dihydro-5H-imidazo[2,1-b] [1,3]oxazines And Their Use Against Myocobacterium Tuberculosis
Patent Cooperation Treaty
PCT/US11/20724
Filed on 2011-01-11

Method For Inducing A Multiclade Immune Response Against HIV Utilizing A Multigene and Multicalde Immunogen

  • Read more about Method For Inducing A Multiclade Immune Response Against HIV Utilizing A Multigene and Multicalde Immunogen
US Patent 8,454,972
Filed on 2011-01-20

Preventing or Treating Viral Infection Using An Inhibitor of The LSD1 Protein, A MAO Inhibitor or an Inhibitor of LSD1 And A MAO Inhibitor

  • Read more about Preventing or Treating Viral Infection Using An Inhibitor of The LSD1 Protein, A MAO Inhibitor or an Inhibitor of LSD1 And A MAO Inhibitor
European Patent
09790772.9
Filed on 2009-07-23

Preventing Or Treating Viral Infection Using An Inhibitor Of the LSD1 Protein, A MAO Inhibitor or An LSD1 And A MAO Inhibitor

  • Read more about Preventing Or Treating Viral Infection Using An Inhibitor Of the LSD1 Protein, A MAO Inhibitor or An LSD1 And A MAO Inhibitor
US Patent 8,916,596
Filed on 2011-01-24

Vaccine And Methods of Use Against Strongyloides Stercoralis Infection

  • Read more about Vaccine And Methods of Use Against Strongyloides Stercoralis Infection
Patent Cooperation Treaty
PCT/US2011/023320
Filed on 2011-02-01

Recombinant Human Parainfluenze Type 1 Viruses (HPIV1s) Containing Mutations In Or Deletion Of The C Protein Are Attenuated In African Green Monkeys And In Ciliated Human Airway Epothelial Cells And Are Potential Vaccine Candidates For HPIV1

  • Read more about Recombinant Human Parainfluenze Type 1 Viruses (HPIV1s) Containing Mutations In Or Deletion Of The C Protein Are Attenuated In African Green Monkeys And In Ciliated Human Airway Epothelial Cells And Are Potential Vaccine Candidates For HPIV1
US Application 13/001,710
Filed on 2011-04-18

A Novel Deletion In The Human Parainfluenze Type 1 (HPIV1) L Gene, Of Amino Acids 1710-1711, Attenuates In Vitro And In Vivo And Is A Promising Mutation For Inclusion In Future HPIV1 Vaccine Candidates

  • Read more about A Novel Deletion In The Human Parainfluenze Type 1 (HPIV1) L Gene, Of Amino Acids 1710-1711, Attenuates In Vitro And In Vivo And Is A Promising Mutation For Inclusion In Future HPIV1 Vaccine Candidates
European Patent
09774482.5
Filed on 2009-07-01

PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES

  • Read more about PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES
Italy
98926055.9
Filed on 1998-05-22

PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES

  • Read more about PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES
United Kingdom
98926055.9
Filed on 1998-05-22

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 354
  • Page 355
  • Page 356
  • Page 357
  • Page 358
  • Page 359
  • Page 360
  • Page 361
  • Page 362
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health